Glenmede Trust’s Apellis Pharmaceuticals APLS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,157	Closed	-$215K	–	1282
2022 Q3	$215K	Buy	+3,157	New	+$215K	﹤0.01%	1068
2020 Q4	–	Sell	-29	Closed	–	–	1251
2020 Q3	$0	Hold	29	–	–	﹤0.01%	2453
2020 Q2	$0	Buy	+29	New	–	﹤0.01%	2437